Article

Coordinated Care Alone May Not Yield ROI, ACPE Told

A federally funded effort to identify high-risk patients and coordinate their care is delivering modest savings, but significant cost reductions may come only after broader payment reforms take hold.

A federally funded effort to identify high-risk patients and coordinate their care is delivering modest savings, but significant cost reductions may come only after broader payment reforms take hold.

The “medical neighborhood” demonstration is generating savings of about 5%, which may not be enough to yield a return on investment for providers, according to preliminary findings shared by Dr. Bruce Bagley, president and CEO of TransforMED. “And that's a problem,” Bagley said, speaking at the American College of Physician Executives annual meeting in Chicago.

TransforMED, a consulting subsidiary of the American Association of Family Physicians dedicated to patient-centered medical homes, is carrying out the experiment with a $20.75 million grant from the CMS Innovation Center, and Bagley cautioned that the CMS had not yet certified the numbers.

Read the full story here: http://bit.ly/1lubXJf

Source: Modern Healthcare

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Leigh Maria Ramos-Platt, MD
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Molly Dean, MSW, Siftwell
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo